More information: Amninder Kaur et al, Saarvienin A—A Novel Glycopeptide with Potent Activity against Drug‐Resistant Bacteria, Angewandte Chemie International Edition (2025). DOI: 10.1002/anie ...

Saarvienin A, a newly identified glycopeptide antibiotic from Amycolatopsis, exhibits strong activity against multidrug-resistant bacteria, including vancomycin-resistant Enterococcus and MRSA.

A team of researchers delved into the intricate world of glycopeptide antibiotics—a vital resource in countering drug-resistant pathogens—to uncover their evolutionary origins. Dr. Demi Iftime ...

An international team of researchers has discovered saarvienin A, a new type of glycopeptide antibiotic. Their findings introduce a compound with strong activity against highly resistant bacterial ...

Dr. Jaime Felipe Guerrero. A team at the University of Vienna, including scientists from the Division of Pharmacognosy and the Mass Spectrometry Center, identified the compound as a novel glycopeptide ...

"Our study is the first one comparing the severe S. aureus infections in the intensive care unit with different levels of glycopeptide resistance adjusted to two of the most significant predictors ...

Many disease biomarkers are glycosylated proteins. Mass spectrometry-based intact glycopeptide identification can provide information on glycosite and the attached glycans. However, the ...

Glycopeptide-based hydrogels are especially promising: In laboratory and animal studies, the nanofiber structures have promoted cellular growth and regulated cell adhesion and migration. A research ...